Iushchuk N D, Frolov V M, Peresadin N A
Ter Arkh. 1991;63(11):19-22.
The clinical efficacy of sodium nucleinate (SN) combined with splenin and quercetin given for lingering Flexner's dysentery in a group of 43 patients was compared with that of routine therapy used in a group of the same number of patients. It has been established that the above drug combination favours the elimination of the pathological symptoms of dyspepsia, the arrest of bacterial isolation and normalization of the immune status. Provided the effect of the combined drug treatment is insufficient, the method of choice is the administration of gene engineering alpha 2-interferon (reaferon) in combination with tocopherol acetate and rectal suppositories containing methyluracil.
将43例慢性弗莱施纳痢疾患者使用核酸钠（SN）联合脾宁和槲皮素治疗的临床疗效与相同数量患者使用常规疗法的疗效进行了比较。已证实上述药物组合有利于消除消化不良的病理症状、阻止细菌分离并使免疫状态正常化。若联合药物治疗效果不佳，首选方法是给予基因工程α2干扰素（重组干扰素）联合醋酸生育酚及含甲基尿嘧啶的直肠栓剂。
